Require “effective” AML/CFT programs. FinCEN would formally distinguish between establishing an AML/CFT program and ...
LAVAL, QC, April 21, 2026 /CNW/ - In recognition of AML World Awareness Day, Servier Canada is highlighting the progress made in precision medicine for Acute Myeloid Leukemia (AML). With TIBSOVO(R) ...
Marcel Buerkler, Director of Advocacy and Industry Intelligence, Canadian Finance and Leasing Association (CFLA) As the ...
Academic-community partnerships can reduce patient travel burdens while maintaining high-quality cancer care, as demonstrated by successful high-dose cytarabine consolidation delivery. A flow ...
The classification of AML and therapeutic options are now largely driven by genetically defined subtypes. Personalization of treatment relies on timely completion and reporting of cytogenetic and ...
"We are thrilled to have received full accreditation from the CPD Group for our AML online courses. This recognition affirms our dedication to delivering valuable educational content in the field of ...
SELLAS Life Sciences Group, Inc. has announced significant milestones in its clinical development of cancer therapies. An Independent Data Monitoring Committee will conduct an interim analysis of the ...
– Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with Next and Final Analysis Planned Upon Reaching 80 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results